|
|
(25 intermediate revisions by 2 users not shown) |
Line 1: |
Line 1: |
| {{drugbox
| | #REDIRECT[[Rifapentine]] |
| | IUPAC_name = 3{[(4-cyclopentyl-1-piperazinyl) imino]methyl} rifamycin
| |
| | image = Rifapentin.png
| |
| | CAS_number = 61379-65-5
| |
| | ATC_prefix = J04
| |
| | ATC_suffix = AB05
| |
| | ATC_supplemental =
| |
| | PubChem = 5462354
| |
| | DrugBank = APRD01217
| |
| | C=47 | H=64 | N=4 | O=12
| |
| | molecular_weight = 877.031 g/mol
| |
| | bioavailability =
| |
| | protein_bound =
| |
| | metabolism =
| |
| | elimination_half-life =
| |
| | excretion =
| |
| | pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| |
| | pregnancy_US = <!-- A / B / C / D / X -->
| |
| | pregnancy_category =
| |
| | legal_AU = <!-- Unscheduled / S2 / S4 / S8 -->
| |
| | legal_UK = <!-- GSL / P / POM / CD -->
| |
| | legal_US = <!-- OTC / Rx-only -->
| |
| | legal_status =
| |
| | routes_of_administration =
| |
| }}
| |
| | |
| {{SI}}
| |
| | |
| ==Overview==
| |
| '''Rifapentin''' (or '''rifapentine''') is an [[antibiotic]] used in the treatment of [[tuberculosis]].
| |
| | |
| {{Antimycobacterials}}
| |
| | |
| | |
| | |
| {{WH}}
| |
| {{WS}}
| |